# OnCo record ascertain-v (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/ascertain-v/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "ascertain-v", "NCT04657081" ;
  schema:name "ASCERTAIN-V"@en ;
  schema:description "ASCERTAIN-V is the study behind the first all-oral AML regimen, approved in May 2026."@en ;
  schema:url <https://onco.cc/trials/ascertain-v/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04657081> ;
  onco:status "positive" ;
  onco:phase "1/2" ;
  schema:startDate "2021-02-09" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/> ;
  onco:drugs <https://onco.cc/drugs/decitabine-cedazuridine/>, <https://onco.cc/drugs/venetoclax/> ;
  onco:companies <https://onco.cc/companies/taiho/> .